Search by year - Any -20252024202320222021202020192018201720162015 26 June 2020 US Multicenter Study Shows Idylla™ Allows Rapid and Accurate Mutation Testing Results Across Different Laboratory Settings Non-regulated information 23 April 2020 Biocartis Announces Development of Idylla™ COVID-19 test Non-regulated information 2 April 2020 Biocartis Announces Publication of 2019 Annual Report Regulated information 26 March 2020 Biocartis Announces Co-commercialization of the SeptiCyte® RAPID Test on Idylla™ (CE IVD) and Provides Update on COVID 19 Impact Regulated information 5 March 2020 Biocartis Announces New Immuno-Oncology Project with Bristol-Myers Squibb Aimed at Registration of Idylla™ MSI test in China Non-regulated information 22 January 2020 Biocartis Enters into Master Collaboration Agreement with AstraZeneca and Initiates EGFR Liquid Biopsy Study Non-regulated information 14 November 2019 Nichirei Biosciences to Initiate Market Introduction of Idylla™ Platform in Japan Non-regulated information 5 November 2019 Five Idylla™ Studies to be Published at ‘Association for Molecular Pathology’ Annual Meeting (US) Non-regulated information 25 October 2019 Biocartis Launches Liquid Biopsy Idylla™ ctEGFR Mutation Assay Non-regulated information 23 September 2019 Five Idylla™ Performance Studies to be Presented at ‘European Society for Medical Oncology’ congress Non-regulated information Pagination First page « First Previous page ‹ Previous … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page Next › Last page Last »